Sudden and Unexplained Post-partum Cardiac Arrest in a Patient with Systemic Lupus Erythematosus: A Case Report

Technical Summary: Sudden and Unexplained Post-partum Cardiac Arrest in a Patient with Systemic Lupus Erythematosus

Problem Statement
Patients with Systemic Lupus Erythematosus (SLE) face a significantly elevated risk of pregnancy complications, including pre-eclampsia and cardiopulmonary events, particularly when comorbidities like antiphospholipid syndrome (APS) are present. However, the specific risk profile for SLE patients who lack active disease flares, renal involvement, or diagnostic APS markers remains less defined. Furthermore, current clinical paradigms often regard regurgitant valvular lesions (such as mitral regurgitation) as relatively benign in pregnancy compared to stenotic lesions, a assumption this case challenges. The core problem addressed is the potential for life-threatening, unexplained post-partum cardiac collapse in SLE patients who appear to lack standard high-risk predictors, and the subsequent management of persistent cardiac sequelae in future pregnancies.

Methodology
This paper presents a detailed case report of a 29-year-old female (G5P2122) with a history of SLE managed on hydroxychloroquine. The methodology involves a chronological clinical analysis of two distinct pregnancies:

1. Index Pregnancy: The patient presented at 35 weeks with dyspnea, hemoptysis, and edema. Despite therapeutic enoxaparin (due to prior deep venous thrombosis and fetal demise) and a lack of diagnostic APS antibodies (anticardiolipin negative), she was initially treated for atypical pneumonia. Following an uneventful vaginal delivery at 37 weeks, she experienced sudden cardiopulmonary collapse eight hours post-partum.
2. Diagnostic and Therapeutic Interventions: The clinical team utilized echocardiography, chest imaging (CT/X-ray), and laboratory monitoring to diagnose flash pulmonary edema, biventricular dysfunction, and severe mitral regurgitation (MR). The patient required intubation, vasopressors, and veno-venous extracorporeal membrane oxygenation (VV-ECMO) for cardiac arrest (pulseless electrical activity).
3. Follow-up and Second Pregnancy: The patient was followed for four years by cardiology, rheumatology, and neurology. She subsequently conceived again, managed via a multidisciplinary team (cardiology, rheumatology, neurology, maternal-fetal medicine), and underwent serial echocardiographic monitoring.

Key Results

• Acute Event: The patient suffered sudden cardiac arrest with return of spontaneous circulation (ROSC) after three rounds of CPR. She required VV-ECMO support due to severe hemodynamic instability and neurologic compromise (seizures).
• Cardiac Findings: Echocardiography revealed biventricular dysfunction and severe mitral regurgitation. While initially attributed to hypertensive emergency, the MR persisted years later with a structurally normal valve but restricted posterior leaflet motion, indicating a non-hemodynamic etiology.
• Laboratory Findings: The patient tested negative for standard APS markers (anticardiolipin) but possessed persistently elevated anti-β2 glycoprotein IgA antibodies.
• Long-term Outcome: The patient recovered with persistent moderate-to-severe MR and a diagnosis of Lance-Adams syndrome.
• Second Pregnancy: Despite medical recommendations against pregnancy due to prior severe complications and persistent MR, the patient conceived. Under strict multidisciplinary monitoring, she delivered a healthy baby without significant peri-partum complications, maintaining normal left ventricular function throughout.

Key Contributions

1. Risk Stratification in "Low-Risk" SLE: The case demonstrates that SLE alone, even in the absence of active flares, nephritis, or diagnostic APS, can confer a high risk of catastrophic obstetric complications.
2. Re-evaluation of APS Criteria: The presence of isolated anti-β2 glycoprotein IgA antibodies in a patient with a history of thrombosis and fetal loss suggests that current APS diagnostic criteria may be insufficient. The authors propose that IgA antibodies should be reconsidered for inclusion in diagnostic algorithms, particularly for SLE patients.
3. Pathophysiology of Regurgitant Lesions: The persistence of severe mitral regurgitation challenges the prevailing assumption that regurgitant valvular lesions are benign in pregnancy. The case suggests that such lesions may require closer monitoring and are not solely hemodynamic in origin.
4. Multidisciplinary Management: The successful outcome of the second pregnancy underscores the efficacy of preconception counseling and coordinated care across cardiology, rheumatology, and maternal-fetal medicine, even in patients with prior severe adverse events.

Significance and Claims
The authors claim that this case highlights critical gaps in the current understanding of cardiac risk in pregnant SLE patients. Specifically, they assert that:

• Patients with SLE remain vulnerable to severe complications regardless of the absence of traditional high-risk features (active disease, APS, nephritis).
• The diagnostic criteria for APS may need broadening to include anti-β2 glycoprotein IgA antibodies to better identify at-risk phenotypes.
• Regurgitant valvular heart disease warrants more rigorous investigation and monitoring in pregnancy, contrary to current World Health Organization guidelines which focus primarily on stenotic disease.
• While pregnancy in high-risk SLE patients carries substantial risks, favorable outcomes are achievable through expert, multidisciplinary management and rigorous monitoring, though such decisions must be made with full awareness of the risks and in alignment with professional society recommendations.

The paper concludes that preconception cardiac counseling and multidisciplinary planning are essential to ensure positive outcomes for this high-risk population.